SYNTHESIS AND X-RAY CRYSTALLOGRAPHY OF 2,4,6-TRIMETHYL-1,4-DIHYDRO-PYRIDINE-3,5-DICARBOXYLIC ACID DIETHYL ESTER

The biologically active 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester has been prepared and characterized by X-ray crystallography. The 1,4-dihydro-pyridine ring is in a flattened boat form, with atoms C3, and N1 being the bow and stern of the boat. Atoms C3 and N1 being 0.1346(12)A and 0.0970(12)A above the mean plane of the 1,4-dihydro-pyridine ring. One of the ethyl ester groups were found to be disordered in two positions at occupancies of 0.517 (19) and 0.483 (19) respectively. There are four molecules of 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid diethyl ester, in the unit cell. Inter­molecular N—H···O hydrogen bonding inter­actions were observed in the crystal lattice which connected the molecules into chain running along b-axis

Educating engineering students in Egypt: a stakeholders’ perspective, using narrative qualitative approach

This is part of a series of three papers in a research project examining engineering education in Egypt. After concerns from several stakeholders about the graduates’ knowledge and skills, a fresh look at the phenomenon is attempted. In this manuscript the views of stakeholders, using narrative approach and analysis was carried out. The methodology followed a narrative approach, conducting stakeholder’s analysis with relevant and related people to engineering education (Coulter and Smith 2009; Sfard and Prusak, 2005). The sample included students & fresh graduates, engineers with several years of experience, others with long experiences, academics, parents and administrative staff, were elicited. The responses were collected by asking two questions via social media. The aim was to obtain a quick idea on how stakeholders perceive engineering education in Egypt, and the enhancements they would like to see. Importance of the study comes from both linking with three papers in series exploring engineering education in Egypt, and the in-depth narrative reflections and insights of stakeholders’ point of view. Four clear requests became evident from the stakeholders responses: the application of modern innovative teaching methods; soft skills training; modern software applications training; and practical technical or industrial training

Synthesis and X-ray crystallography of N,N'-di(2-hydroxybenzylidene)hydrazine

The biologically active N,N'-di(2-hydroxybenzylidene)hydrazine has been synthesized and specifically characterized by X-ray crystallography. There are two molecules of N,N'-di(2-hydroxybenzylidene)hydrazine, C14H12N2O2, in the unit cell. The N,N'-di(2-hydroxy benzylidene)hydrazine molecule is planar, with maximum deviation from the mean plane being less than 0.028(2) Å. Intramolecular O-H···N hydrogen bonding interactions were observed in the crystal lattice which connected the molecules into chain running along b-axis

Normal testicular tissue elasticity by sonoelastography in correlation with age

AbstractPurposeThis research aimed to study the correlation between the normal testicular tissue elasticity as detected by real time sonoelastography with the age.Materials and methodsThe study was conducted upon 63 adult healthy volunteers. Each volunteer was subjected to real time sonoelastography measuring the strain ratio of testicular tissues and their elasticity scores.ResultStrain ratios of the examined testes ranged from 0.27 to 0.38, with a mean strain of 0.33 and a standard deviation of 0.03. Elasticity score of the examined testes included ES1 in 62 testes (49%), ES2 in 58 testes (46%) and ES3 in 6 testes (5%). No ES4 or ES5 was elicited in this group. High negative correlation is found between the age and both the testicular volume and the strain ratio, while there is no correlation between age and the elasticity score of testes.ConclusionNormal testicular tissues as studies by sonoelastography show strong correlation between the age and the testicular volume as well as the strain ratio

1-(Adamantan-1-ylcarbon­yl)-3-(2,6-difluoro-4-hy­droxy­phen­yl)thio­urea

In the title mol­ecule, C18H20F2N2O2S, the 2,6-difluoro-4-hy­droxy­phenyl ring and the carbonyl­thio­urea group are each essentially planar, with maximum deviations of atoms from their mean planes of 0.0113 (14) and 0.1017 (15) Å, respectively; the dihedral angle between these two planes is 71.03 (6)°. An intra­molecular N—H⋯O hydrogen bond occurs. In the crystal, N—H⋯O and O—H⋯S hydrogen bonds connect the mol­ecules into chains running diagonally across the bc plane. C—H⋯S and C—H⋯F contacts are also observed

2-Amino-6-(dimethyl­amino)pyridine-3,5-dicarbonitrile

The title compound, C9H9N5, is slightly twisted from planarity, with a maximum deviation of 0.0285 (13) Å from the pyridine plane for the C atom bearing the amino group. The cyano groups are on different sides of the pyridine plane, with C- and N-atom deviations of 0.072 (3)/0.124 (4) and −0.228 (4)/−0.409 (5) Å from the pyridine plane. In the crystal, N—H⋯N and C—H⋯N hydrogen bonds connect the mol­ecules into zigzag chains running along the c axis

Overview On Surgical Management Of Overactive Bladder

Overactive bladder syndrome is a persistent and incapacitating disorder that has profound medical, psychological, and social implications, greatly impacting the wellbeing of countless individuals globally. A significant number of individuals experience urine urgency, which can be extremely bothersome. The primary indicator of overactive bladder (OAB) is a sense of urgency, often accompanied by increased urine frequency and nocturia. After ruling out other medical conditions with similar symptoms, the initial approach to managing OAB is providing guidance on fluid consumption and bladder training. If needed, antimuscarinic medicines may be added as a supplement. If patients have significant distress from OAB symptoms even after maximizing medicinal treatment, they may choose to undergo invasive procedures. There is currently a limited understanding of the hierarchical structure of central nervous system control. However, the use of functional imaging is starting to reveal the difficulties that need to be addressed in this area. Current research is exploring the use of botulinum neurotoxin-A injection, oral β3-adrenergic agonists, and innovative methods for nerve stimulation as potential therapies. The inherent subjectivity of urine urgency, the absence of animal models, and the complex pathophysiology of overactive bladder (OAB) pose substantial obstacles to achieving effective clinical therapy

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.

We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global sequence data. Several variants within nucleocapsid and ORF3a epitopes have arisen independently in multiple lineages and result in loss of recognition by epitope-specific T cells assessed by IFN-γ and cytotoxic killing assays. Complete loss of T cell responsiveness was seen due to Q213K in the A∗01:01-restricted CD8+ ORF3a epitope FTSDYYQLY207-215; due to P13L, P13S, and P13T in the B∗27:05-restricted CD8+ nucleocapsid epitope QRNAPRITF9-17; and due to T362I and P365S in the A∗03:01/A∗11:01-restricted CD8+ nucleocapsid epitope KTFPPTEPK361-369. CD8+ T cell lines unable to recognize variant epitopes have diverse T cell receptor repertoires. These data demonstrate the potential for T cell evasion and highlight the need for ongoing surveillance for variants capable of escaping T cell as well as humoral immunity.This work is supported by the UK Medical Research Council (MRC); Chinese Academy of Medical Sciences(CAMS) Innovation Fund for Medical Sciences (CIFMS), China; National Institute for Health Research (NIHR)Oxford Biomedical Research Centre, and UK Researchand Innovation (UKRI)/NIHR through the UK Coro-navirus Immunology Consortium (UK-CIC). Sequencing of SARS-CoV-2 samples and collation of data wasundertaken by the COG-UK CONSORTIUM. COG-UK is supported by funding from the Medical ResearchCouncil (MRC) part of UK Research & Innovation (UKRI),the National Institute of Health Research (NIHR),and Genome Research Limited, operating as the Wellcome Sanger Institute. T.I.d.S. is supported by a Well-come Trust Intermediate Clinical Fellowship (110058/Z/15/Z). L.T. is supported by the Wellcome Trust(grant number 205228/Z/16/Z) and by theUniversity of Liverpool Centre for Excellence in Infectious DiseaseResearch (CEIDR). S.D. is funded by an NIHR GlobalResearch Professorship (NIHR300791). L.T. and S.C.M.are also supported by the U.S. Food and Drug Administration Medical Countermeasures Initiative contract75F40120C00085 and the National Institute for Health Research Health Protection Research Unit (HPRU) inEmerging and Zoonotic Infections (NIHR200907) at University of Liverpool inpartnership with Public HealthEngland (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford.L.T. is based at the University of Liverpool. M.D.P. is funded by the NIHR Sheffield Biomedical ResearchCentre (BRC – IS-BRC-1215-20017). ISARIC4C is supported by the MRC (grant no MC_PC_19059). J.C.K.is a Wellcome Investigator (WT204969/Z/16/Z) and supported by NIHR Oxford Biomedical Research Centreand CIFMS. The views expressed are those of the authors and not necessarily those of the NIHR or MRC

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely